REGAIN BIOSURGERY

Hemostasis is a very important procedure in surgery. It's estimated that its global market is nearly 2.2 billion USD in 2018, and its profit in the next seven years is expected to continue to grow. To satisfy this unmet medical need and grab the business opportunity, our team combined experts from medicine, technology, research, and business, and designed a novel multifunctional hemostatic platform based on "nanomedical" materials, namely, polyurethane nanoparticles (PU NPs). PU NP has been proved to exhibit an anti-inflammatory effect in vitro, and product prototype has been demonstrated to induce almost no foreign body reactions and probably exhibit neuroprotective effects in vivo.